SCHEMBL679939

SCHEMBL679939

COc1ccccc1Oc1ccc(C(=O)NS(C)(=O)=O)cc1

nearest known ligand 0.60

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 3/20 0.60
KMT2A Q03164 3/20 0.60
RAB9A P51151 1/20 0.60
HTT P42858 3/20 0.54
ALDH1A1 P00352 2/20 0.54
MAPK1 P28482 1/20 0.54
L3MBTL1 Q9Y468 1/20 0.54
EZH2 Q15910 1/20 0.53
MCL1 Q07820 4/20 0.51
BCL2L1 Q07817 3/20 0.51
GAA P10253 1/20 0.50
MTNR1B P49286 1/20 0.48
TTR P02766 1/20 0.48
SCN9A Q15858 1/20 0.47
SCN3A Q9NY46 1/20 0.47
TSHR P16473 1/20 0.46
LPAR1 Q92633 1/20 0.45
LPAR5 Q9H1C0 1/20 0.45
LMNA P02545 1/20 0.45
CA1 P00915 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL679956 0.86 MAPK14 (0.55) MEN1KMT2ARAB9AHTTALDH1A1
SCHEMBL678866 0.85 SCN9A (0.53) MEN1KMT2ARAB9AALDH1A1GAA
SCHEMBL15101087 0.85 MEN1 (0.56) MEN1KMT2ARAB9AHTTALDH1A1
SCHEMBL680509 0.85 SCN3A (0.50) MEN1KMT2ARAB9AALDH1A1L3MBTL1
SCHEMBL680618 0.84 MAPK14 (0.54) MEN1KMT2AEZH2SCN9ASCN3A
SCHEMBL680159 0.84 CXCL8 (0.59) MCL1BCL2L1SCN9ASCN3ALPAR1
SCHEMBL679137 0.84 RORC (0.52) MEN1KMT2ARAB9AMCL1BCL2L1
SCHEMBL680757 0.84 SCN9A (0.53) MEN1KMT2ARAB9AALDH1A1MAPK1
SCHEMBL678507 0.84 SCN9A (0.53) MEN1KMT2ARAB9AALDH1A1MAPK1
SCHEMBL680001 0.83 SCN9A (0.51) MEN1KMT2ARAB9AGAASCN9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2593427-B1 SULFONAMIDE DERIVATIVES AS NAV1.7 INHIBITORS FOR THE TREATMENT OF PAIN PFIZER LTD (GB) 2014-12-24 EP disclosed
US-20120010207-A1 Chemical Compounds PFIZER LIMITED (GB) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120010207-A1 Chemical Compounds SCN1A, SCN1B, SCN7A MEN1 2843/4885KMT2A 2539/4885RAB9A 968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.